Raynaud phenomenon is chronic vasospasm of the fingers, ears, nose and toes that occurs in response to stress or cold exposure, with a prevalence rates of 11% in women and 8% in men according with EEUU statistics. Secondary Raynaud phenomenon is associated with another disease like autoimmune disease. In our clinical center since 2010, 22 patients with secondary severe Raynaud syndrome (Lupus, scleroderma-CREST, vasculitis, Rheumatoid Arthritis) were recruited to the program of autologous cellular therapies previously sign of voluntary consent and approval of the medical ethical committee maintained their standard pharmacological therapy.
Arterial regeneration and clinical improvement of secondary autoimmune Raynaud’s syndrome with autologous bone marrow mononuclear cells (aBM-MNC). early results of phase II clinical trial
- Post author:2by2host
- Post published:January 16, 2018
- Post category:Articles / Stem Cells
Please Share This Share this content
- Opens in a new window Twitter
- Opens in a new window Facebook
- Opens in a new window Google+
- Opens in a new window Pinterest
- Opens in a new window LinkedIn
- Opens in a new window Viber
- Opens in a new window VK
- Opens in a new window Reddit
- Opens in a new window Tumblr
- Opens in a new window Viadeo
- Opens in a new window WhatsApp